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Background and purpose   The aim of the present study was 
to assess incidence of and risk factors for infection after hip 
arthroplasty in data from 3 national health registries. We inves-
tigated differences in risk patterns between surgical site infec-
tion (SSI) and revision due to infection after primary total hip 
arthroplasty (THA) and hemiarthroplasty (HA).
Materials and methods   This observational study was based 
on prospective data from 2005–2009 on primary THAs and HAs 
from the Norwegian Arthroplasty Register (NAR), the Norwegian 
Hip Fracture Register (NHFR), and the Norwegian Surveillance 
System for Healthcare–Associated Infections (NOIS). The Nor-
wegian Patient Register (NPR) was used for evaluation of case 
reporting. Cox regression analyses were performed with revi-
sion due to infection as endpoint for data from the NAR and the 
NHFR, and with SSI as the endpoint for data from the NOIS.
Results   The 1–year incidence of SSI in the NOIS was 3.0% 
after THA (167/5,540) and 7.3% after HA (103/1,416). The 1–year 
incidence of revision due to infection was 0.7% for THAs in the 
NAR (182/24,512) and 1.5% for HAs in the NHFR (128/8,262). 
Risk factors for SSI after THA were advanced age, ASA class 
higher than 2, and short duration of surgery. For THA, the risk 
factors for revision due to infection were male sex, advanced age, 
ASA class higher than 1, emergency surgery, uncemented fixa-
tion, and a National Nosocomial Infection Surveillance (NNIS) 
risk index of 2 or more. For HAs inserted after fracture, age less 
than 60 and short duration of surgery were risk factors of revision 
due to infection.
Interpretation   The incidences of SSI and revision due to infec-
tion after primary hip replacements in Norway are similar to 
those in other countries. There may be differences in risk pattern 
between SSI and revision due to infection after arthroplasty. The 
risk patterns for revision due to infection appear to be different 
for HA and THA.

Increasing incidence of revision due to infection after primary 
total hip arthroplasty (THA) has been observed in different 
countries during the last decade (Kurtz et al. 2008, Dale et al. 
2009, Pedersen et al. 2010). There have been several studies 
on incidence of and risk factors for infection based on data 
from surveillance systems (Ridgeway et al. 2005, Mannien et 
al. 2008), arthroplasty (quality) registers (Berbari et al. 1998, 
Dale et al. 2009, Pedersen et al. 2010), and administrative 
databases (Mahomed et al. 2003, Kurtz et al. 2008, Ong et al. 
2009). There have been reviews on incidence of and risk fac-
tors for infection after hip arthroplasty, based on publications 
from databases with different definitions of infection (Urqu-
hart et al. 2009, Jämsen et al. 2010a). Superficial surgical site 
infections (SSIs) may have risk factors that are different from 
those of full surgical revisions due to infection. Furthermore, 
THA and hip hemiarthroplasty (HA) may have different pat-
terns of risk of infection (Ridgeway et al. 2005, Cordero–
Ampuero and de Dios 2010).
In the present study, we used data from 3 national health 
registries in Norway to assess incidence and some risk factors 
for infection after primary hip arthroplasty. Differences in risk 
patterns between SSI and revision due to infection were inves-
tigated for HA and THA.
Material and methods
In Norway, 3 national health registries representing 2 differ-
ent surveillance systems record information on primary hip 
replacement surgery and postoperative infections: the Nor-
wegian Arthroplasty Register (NAR) and the Norwegian Hip 
Fracture Register (NHFR). These are quality registers, while 
the Norwegian Surveillance System for Healthcare–Asso-
ciated Infections (NOIS (Norwegian acronym)) is an infec-
tion surveillance system. We compared these registries for Acta Orthopaedica 2011; 82 (6): 646–654  647
infectious endpoints after primary THA or HA over the years 
2005–2009. In addition, data from a fourth health registry, the 
Norwegian Patient Register (NPR), were used to assess the 
reporting of primary procedures to the 3 registries.
The Norwegian Surveillance System for Healthcare–
Associated Infections (NOIS)
The NOIS is based on a modified version of Hospitals in 
Europe Link for Infection Control through Surveillance 
(HELICS 2004). The aims are to survey, describe, and evalu-
ate the incidence of surgical site infection (SSI) after certain 
procedures. Furthermore, the intention is to assess effects of 
prophylactic interventions and discover variations in SSI. 
Since 2005, it has been mandatory for all Norwegian hos-
pitals to report arthroplasty and 4 other procedures (Caesar-
ean section, coronary bypass, appendectomy, and cholecys-
tectomy) over a 3–month period every year (September to 
November). The data are collected either electronically from 
the patients’ medical records or manually (by infection–con-
trol nurses) into a standardized case report form. The infor-
mation collected includes hospital affiliation, patient charac-
teristics, date of admission, surgery, discharge, first infection 
and last follow–up, type of arthroplasty, type of infection, the 
source of diagnosis (patient or physician), and reoperations. 
For this study, only infections verified by a medical doctor 
were included. Verification of SSI was from a form signed by 
a general physician or from the hospital medical records if 
the patient had SSI diagnosed at a hospital. The endpoint in 
the NOIS was SSI, defined according to the CDC guidelines. 
The CDC–defined organ/space SSI category was combined 
with the deep incisional SSI category. Reoperations reported 
to the NOIS comprised all types of surgical procedures due to 
infection. If no infection was recorded, the patient was cen-
sored at death or last date of surveillance. Endpoint evalua-
tion was done at discharge, by questionnaire to the patient, 
and by evaluation of the medical records at 30 and 365 
days postoperatively. 30 days were defined as the minimum 
follow–up time for inclusion. The procedures included were 
primary THAs and HAs with the NOMESCO codes NFB 02, 
–12, –20, –30, and –40. In the NOIS, 6,956 hip arthroplasties, 
including 5,540 THAs and 1,416 HAs, were eligible for 
analysis (Figure 1). In contrast to the NHFR, the NOIS also 
includes HAs inserted for causes other than femoral neck 
fracture. With this exception, THAs in the NOIS should also 
be reported to the NAR whereas HAs should be reported to 
the NHFR.
The Norwegian Arthroplasty Register
Since its inception in 1987, the NAR has registered data on 
primary THAs and THA revisions. This includes the patient’s 
identity and characteristics, the indication for THA, the surgi-
cal procedure, the implant, and revisions. The unique identifi-
cation number of each Norwegian citizen can be used to link 
the primary THA to a later revision (Havelin et al. 2000).
Number of primary THAs and HAs (red squares) included in the NOIS, the NAR, and the NHFR, including number of 
arthroplasties with missing data on the confounders and incomplete 30–day and 1–year follow–up. 
a The NOIS registers arthroplasties 3 months every year. Not all hospitals that reported to the NAR and the NHFR reported to 
the NOIS. (NOIS is a Norwegian acronym).
TOTAL HIP ARTHROPLASTY HEMIARTHROPLASTY
Primary arthroplasties
reported
Arthroplasties with
incomplete variables
Arthroplasties with
complete variables
Arthroplasties with less
than 30 days follow up
Arthroplasties with 
30 days follow up
Arthroplasties with less
than 1 year follow up
Arthroplasties with 
1 year follow up
The Norwegian
Surveillance System
for Healthcare
Associated Infections
(NOIS) a
The Norwegian
Arthroplasty Register
(NAR) 
The Norwegian Hip
Fracture Register
(NHFR) 
The Norwegian
Surveillance System
for Healthcare
Associated Infections
(NOIS) a
n = 5,959 n = 33,386 n = 1,705 n = 11,911
n = 5,650
n = 309 n = 2,300 n = 185 n = 939
n = 110 n = 622 n = 104 n = 265
n = 3,599 n = 5,952 n = 866 n = 1,445
n = 31,086 n = 1,520 n = 10,972
n = 5,540 n = 30,464 n = 1,416 n = 10,707
n = 1,941 n = 24,512 n = 550 n = 8,262648  Acta Orthopaedica 2011; 82 (6): 646–654
Revision due to deep infection of the implant was the infec-
tion endpoint in the NAR in the present study, and was defined 
as removal or exchange of the whole or part of the prosthesis 
with deep infection reported as the cause of revision. Isolated 
soft tissue revisions were not reported. The case report form 
is filled in by the surgeon immediately after surgery. Detailed 
information on the arthroplasty was transformed into the fol-
lowing NOMESCO groups: cemented THAs (NFB 40), unce-
mented THAs (NFB 20), and hybrid THAs (NFB 30). The 
NAR does not register HAs. All THAs were followed until 
their first revision due to deep infection or revision for other 
causes, until the date of death or emigration of the patient, 
or until December 31, 2009. In the NAR, 31,086 THAs were 
eligible for analysis (Figure).
The Norwegian Hip Fracture Register
The NHFR has the same administrative foundation and purpose 
as the NAR. Since January 1, 2005, all hip fractures treated 
surgically and later revisions have been reported on a similar 
case report form to that for registration in the NAR (Gjertsen et 
al. 2008). Procedures included were HAs performed as a pri-
mary operation for a femoral neck fracture and HAs inserted 
secondary to failure of the primary osteosynthesis of a femo-
ral neck fracture. THAs as primary emergency treatment or 
secondary planned treatment of femoral neck fractures were 
registered in the NAR. As for the NAR, the endpoint was revi-
sion of the implant due to infection. The groups cemented HA 
(NFB 12) and uncemented HA (NFB 02) were defined based 
on detailed information about the implant type and fixation 
reported to the NHFR. HAs inserted for causes other than hip 
fracture or complications after hip fracture (i.e. osteoarthritis 
or malignancies) were not registered in the NHFR. All HAs 
were followed until their first revision due to deep infection 
or revision for other causes, until the date of death or emigra-
tion of the patient, or until December 31, 2009. In the NHFR, 
10,972 HAs were eligible for analysis (Figure).
The Norwegian Patient Register
The NPR is a national administrative health register. It is com-
pulsory by law to report medical treatment to the NPR, and it 
is the basis of funding in Norwegian hospitals. Primary THAs 
and HAs with the NOMESCO codes NFB 02, –12, –20, –30, 
and –40 were included for the assessment of case reporting, 
regardless of diagnosis.
Statistics
Descriptive statistics were used for demographics and surgery–
related data. Data from NOIS and the merged NAR and NHFR 
data were analyzed separately. The 1–year incidences of SSI, 
reoperation, and revision due to infection were estimated by 
dividing the number of events reported during the first post-
operative year by the number of primary arthroplasties. Cox 
regression analyses were performed to establish risk factors 
for revision due to deep infection or SSI, and also 1–year 
probabilities (risks) of these events (1 minus 1–year survival 
(%)). Adjusted hazard rate ratios, hereafter called risk ratios 
(RRs), were estimated for each risk factor with 95% confi-
dence intervals (CIs). The risk factors evaluated were age, sex, 
American Society of Anesthesiologists classification (ASA 
class), duration of surgery, type of surgery (emergency or 
planned), and method of fixation of the prosthesis (Table 1). 
Adjusted risk of SSI after HA relative to THA was assessed 
in the NOIS, whereas adjusted risk of revision due to infec-
tion after HA relative to THA was analyzed in the merged 
NAR–NHFR data. In addition, we calculated and assessed 
the National Nosocomial Infection Surveillance (NNIS) risk 
index, which comprise duration of surgery (> 75th percentile 
for the procedure), co–morbidity of the patient (ASA class 
> 2), and contamination of the wound peroperatively (Man-
gram et al. 1999). In the NAR and NHFR, we assumed that 
there was no contamination. The 75 percentile duration of sur-
gery as reported was used (in the NOIS, HA 94 min and THA 
108 min; in the NHFR, HA 90 min; and in the NAR, THA 
Table 1. Distribution of the assessed risk factors in the registers: 
THAs and HAs included from the Norwegian Surveillance System 
for Healthcare Associated Infections (NOIS), THAs included from in 
the Norwegian Arthroplasty Register (NAR) and HAs included from 
in the Norwegian Hip Fracture Register (NHFR). 
  Total hip arthroplasty  Hemiarthroplasty
Register  NOIS  NAR  NOIS NHFR
Number of procedures  5,540  31,086  1,416  10,972
Risk factor % 
Agegroup (years) 
 <60  19  20  2  1
 60–69  31  30  4  5
 70–79  34  34  22  24
 80–89  15  15  56  54
  ≥90  1  1  16 15
Sex
 female  66  67  74  74
 male  34  33  26  26
ASA score 
 1  18  29  2  5
 2  65  52  42  35
  ≥3  17 19  56 60
Duration of surgery (Min) 
 <60  6  7  19  22
  60–89  41   40  50  47 
 90–119  33  35  22  24
  ≥120  19 19  8  8
Type of surgery 
 emergency  3  2  74  86
 planned  97  98  26  14
Method of fixation 
 cemented  64  65  81  81
 uncemented  16  16  19  19
 hybrid  20  18
NNIS index 
 0  63  64  32  31
 1  32  31  54  56
  ≥2  5  5  14 13Acta Orthopaedica 2011; 82 (6): 646–654  649
110 min), and not the 120 min estimated for HA and THA 
in the HELICS guidelines. Follow–up for the NAR and the 
NHFR analyses was 0–5 years and for the NOIS it was 0–1 
year. However, to ensure similar follow–up for all 3 registries, 
additional analyses were performed with follow–up restricted 
to 1 year for all available cases. Stratified analyses were per-
formed on the NOIS data with deep SSI as separate endpoint. 
Any p–values of less than 0.05 were considered statistically 
significant. SPSS software version 18.0 and PASS 2008 soft-
ware were used for statistical analysis.
Results
Case reporting and distribution of risk factors
32 hospitals reported THAs to the NPR and the NAR during 
the study period. 30 hospitals reported THAs to the NOIS; 
there was an increase in hospitals reporting THA, from 8 in 
the first year.
29 hospitals reported HAs to the NPR, whereas 27 reported 
HAs to the NHFR and 26 reported HAs to the NOIS over 
the study period. The number of hospitals reporting HAs 
increased from 5 to 26 in the NOIS and from 26 to 27 in the 
NHFR. 33,466 primary THAs and 12,069 primary HAs were 
reported to the NPR during the study period. The comparable 
number of procedures reported to each of the other registries 
is presented in Figure 1. The distribution of risk factors was 
similar for THAs in the NOIS and the NAR, and for HAs in 
the NOIS and the NHFR (Table 1). The exception was ASA 
classification (Table 1).
Incidence and risk of infection
The 1–year incidence of SSI was 3.0% after primary THA 
(Table 2). 6/94 of the superficial SSIs and 52/73 of the deep 
SSIs after THA in the NOIS were reported to have been reop-
erated due to the infection, whereas in the NAR the 1–year 
incidence of revision due to infection was 0.7% (Table 2).
In primary HAs, the 1–year incidence of SSI was 7.3% 
(Table 2). 50/51 of the reoperations due to infection after HA 
in the NOIS were due to deep SSIs, and 50/72 of the deep SSIs 
were reported to have been reoperated. 1.5% of the HAs were 
reported to the NHFR to have been revised due to infection 
(Table 2).
In the NOIS, the adjusted risk of SSI after HA compared to 
THA was 1.2 (CI: 0.8–1.9). The adjusted risk of revision due 
to infection was 1.8 times higher for HAs (CI: 1.2–2.7) than 
for THA in the merged NAR/NHFR data.
Time to SSI and revision due to infection
For THAs, the median postoperative time to diagnosis of SSI 
was 16 (2–214) days. Median time to revision due to infection 
was 29 (4–343) days, when restricting follow–up to 1 year, 
and 47 (4–1,782) days with 0–5 years of follow–up. For HAs, 
the median postoperative time to SSI was 15 (2–79) days. 
Median time to revision due to infection was 20 (4–304) days 
with 1–year follow up and 20 (4–701) days with 0–5 years of 
follow–up. 72% of the SSIs in the NOIS were identified in 
the post discharge surveillance, but only 9 cases of SSI were 
identified between 30 and 365 days postoperatively. 
Risk factors for infection after THA
The following factors were associated with increased risk of 
revision due to infection: 70–89 years of age, male sex, and 
ASA class higher than 1 (Table 3). Emergency surgery as 
opposed to planned surgery and a National Nosocomial Infec-
tion Surveillance Systems (NNIS) risk index of > 1 were also 
associated with a higher risk of revision due to infection after 
THA. Uncemented fixation of the prosthesis had a 50% higher 
risk of revision due to infection compared to cemented THAs.
Risk factors for SSI after THA were short duration of sur-
gery (< 60 min), which was also the finding when cemented, 
uncemented, and hybrid fixations were analyzed separately. 
Patients older than 80 years of age also had higher risk of 
SSI than those who were less than 60 years of age. The risk 
patterns for SSI and revision due to infection were different 
regarding effects of gender, duration of surgery < 60 min, and 
method of fixation. Separate analyses of all cases with 1–year 
follow–up in the NOIS and restricted follow–up of 1 year for 
the NAR as in the NOIS did not change the findings concern-
ing risk factors for SSI or revision due to infection. Restriction 
to deep incisional SSI in the NOIS had only minor effects on 
the risk estimates.
Risk factors for infection after HA
In the NHFR, age less than 60 years and duration of sur-
gery of less than 60 min were associated with increased risk 
of revision due to infection (Table 4). No risk factors were 
identified for SSI after HA. HA had a different risk profile 
from that of THA, for both SSI and revision due to infection 
(Tables 3 and 4).
Table 2. 1-year incidence of SSI and reoperation after primary 
arthroplasties as reported to the Norwegian Surveillance System 
for Healthcare Associated Infections (NOIS) and 1-year incidence of 
revisions due to infection after THAs as reported to the Norwegian 
Arthroplasty Register (NAR) and after HAs as reported to the Nor-
wegian Hip Fracture Register (NHFR)
  Total hip arthroplasty  Hemiarthroplasty
Registera  Endpoint  1–year incidence  1–year incidence
NOIS 
  Sugical Site Infection  3.0% (167/5,540)  7.3% (103/1,416)
  Superficial SSI  1.7% (94/5,540)  2.2% (31/1,416)
  Deep SSI  1.3% (73/5,540)  5.1% (72/1,415)
  SSI reoperated  1.0% (58/5,540)  3.6% (51/1.416)
NAR / NHFR
  Revision due to infection  0.7% (182/24,512)  1.5% (128/8,262)
a The NOIS and the NAR/NHFR represents different selections of 
cases650  Acta Orthopaedica 2011; 82 (6): 646–654
Discussion
The 3.0% incidence of SSI after primary THA is similar to 
incidences of SSI reported from other European countries 
with similar surveillance systems to those of Norway (range 
0.9–4.6%) (Ridgeway et al. 2005, HELICS 2006, The Health 
Protection Agency 2007, Mannien et al. 2008). The 1–year 
incidence of revision due to infection (0.7% for THA) in the 
NAR is similar to results from other Scandinavian arthroplasty 
registries (Havelin et al. 2009). Comparisons of incidence of 
infection after arthroplasty across countries are complicated 
due to differences in definitions, in completeness of case 
reporting, and in post–discharge surveillance (Wilson et al. 
2007).
The 1–year incidence of SSI of 7.3% after primary HA 
appears to be high compared to the results reported from the 
English mandatory surveillance (3.6–5.0%), which has also 
reported that HA patients had 2.5 times greater risk of devel-
oping SSI than THA patients (Ridgeway et al. 2005, The 
Health Protection Agency 2007). Similar differences between 
SSI after HA and SSI after THA were also reported by Wilson 
from the HELICS collaboration (2007). One explanation for 
the higher infection rates after HA may be differences in 
patient population, including how frail individuals are from a 
Table 3. Risk factors for infection after THA: Adjusted risk of surgical site infection (SSI) after primary THAs in the Norwegian Surveillance 
System for Healthcare Associated Infections (NOIS), and adjusted risk of revision due to infection in the Norwegian Arthroplasty Register 
(NAR) for different risk factors. Each risk factor was adjusted for the other risk factors in the table except NNIS index
  Total hip arthroplasty
Register: NOIS  NAR
Number infected / included:  167 / 5,540 (3.0%)  236 / 31,086 (0.8%)
Risk factor  A  B  C  D  E  F  G  H  I  J  K  L
Age group (years) 
  <  60  1,067 23 1     2.4  6,114 34  1     0.4
  60–69  1,740  46  1.2 0.7–2.1 0.5  2.7  9,320  61  1.3 0.8–1.9  0.3  0.4
  70–79  1,882  59  1.4 0.8–2.4 0.2  3.3  10,703  95  1.7 1.1–2.6  0.02  0.6
  80–89  816  36  1.9 1.1–3.5 0.03  4.2  4,766  45  1.8 1.1–3.0  0.02  0.8
  ≥90  35  3  3.8 1.1–13  0.04  7.4  183  1  1.0 0.1–7.4  1.0  0.5
Sex 
  female  3,676  103 1     2.7  20,922  113  1     0.4
  male  1,864  64  1.3 0.9–1.8 0.1  3.6  10,164  123  2.4 1.8–3.1 <0.001  1.0
ASA score
  1  1,010 18 1     2.1  8,964 46  1     0.4
  2  3,608  109  1.5 0.9–2.5 0.1  3.1  16,148  125  1.5 1.1–2.2  0.02  0.6
  ≥3  922  40  1.9 1.0–3.4 0.04  4.1  5,974  65  2.0 1.3–2.9  0.001  0.7
Duration of surgery (min)
  <60  357  20  2.4 1.4–4.0 0.001 6.8  2,045  15  1.0 0.6–1.8  0.9  0.6
  60–89  2,294 56 1     2.4  12,427 84  1     0.5
  90–119  1,822  59  1.3 0.9–1.9 0.1  3.2  10,745  84  1.1 0.8–1.5  0.5  0.5
  ≥120  1,067  32  1.2 0.8–1.9 0.4  3.2  5,869  53  1.3 0.9–1.8  0.2  0.5
Type of surgery 
  emergency  183  10  1.8 0.9–3.4 0.08  6.6  609  9  2.2 1.1–4.3  0.02  1.3
  planned  5,357  157 1     2.9  30,477  227  1     0.5
Method of fixation 
  cemented  3,547  111 1     2.9  20,308  159  1     0.5
  unemented  902  25  1.0 0.7–1.7 0.8  3.5  5,110  43  1.5 1.0–2.2  0.03  0.8
  hybrid  1,091  31  1.1 0.7–1.7 0.7  3.4  5,668  34  1.1 0.7–1.6  0.7  0.6
NNIS index a 
  0  3,480 94 1     2.8  19,729  129  1     0.5
  1  1,784  64  1.3 0.9–1.7 0.2  3.8  9,760  87  1.3 1.0–1.7  0.08  0.6
  ≥2  267  9  1.0 0.5–2.0 1.0  3.5  1,597  20  1.7 1.1–4.4  0.02  0.6
A  Number of primary arthroplasties included 
B  Number of SSIs 
C Adjusted risk of SSI  
D 95% CI
E P-value
F  Adjusted 1–year SSI percent  
G Number of primary THAs included 
H Number of revisions due to infection 
I  Adjusted risk of revision due to infection  
J  95% CI 
K P-value 
L  Adjusted 1–year revision percent 
a Adjusted for sex, age, type of surgery and method of fixationActa Orthopaedica 2011; 82 (6): 646–654  651
medical standpoint (Gjertsen et al. 2008, Hahnel et al. 2009). 
HA patients were generally older, with more co–morbidity 
than the THA patients, and the majority of HA patients had 
had surgery due to a trauma (hip fracture). Ridgeway found, 
as in the present study, that there was no difference in the risk 
of SSI between HA and THA patients after adjusting for ASA 
score, age, duration of surgery, and procedures performed 
after trauma. In contrast, we found an increased risk of revi-
sion due to infection after HA as compared to after THA.
Male sex was a risk factor for revision due to infection after 
THA, as shown in some other studies (Ong et al. 2009, Ped-
ersen et al. 2010), whereas yet other studies have not found 
this (Mahomed et al. 2003, Ridgeway et al. 2005). It also 
appears that males have a relatively high risk of revision due 
to infection—as compared to SSI. One reason may be differ-
ent thresholds for referral or revision surgery, or the fact that 
surgery on males can cause a greater degree of surgical trauma 
and tissue damage (Franks and Clancy 1997, Borkhoff et al. 
2008, Pedersen et al. 2010). There may also be differences in 
bacterial flora or carriage between men and women (Skramm 
et al. 2007).
The risk of infection increased with age, for both SSI and 
revision due to infection after THA, and this was also found 
to be the trend for the oldest HA patients. The exception was 
HAs in patients aged less than 60 years, who had greater than 
3 times higher risk of revision due to infection than patients 
between 80 and 90 years of age. In Norway, the common 
policy is to use HA in young patients only if they have many 
risk factors for complications or have a short life expectancy. 
High age has been found to be an independent risk factor for 
SSI in some other studies (Ridgeway et al. 2005, Geubbels 
et al. 2006). In contrast, without adjustment for ASA class, 
high age was not found to be a risk factor for revision due to 
infection in a previous publication from the NAR involving 
THAs from the period 1987–2007 (Dale et al. 2009). A recent 
large Danish study, adjusted for co–morbidity, did not find age 
to be a risk factor (Pedersen et al. 2010). Having a primary 
THA at a young age may indicate co–morbidity, and thereby 
increased susceptibility to infection. Among very old patients 
the most healthy are selected to undergo THA, and may there-
fore have reduced susceptibility to infection compared to the 
average population at that age (Lie et al. 2000). Furthermore, 
Table 4. Risk factors for infection after HA: Adjusted risk of surgical site infection (SSI) after primary HAs in the Norwegian Surveillance 
System for Healthcare Associated Infections (NOIS), and adjusted risk of revision due to infection in the Norwegian Hip Fracture Register 
(NHFR) for different risk factors. Each risk factor was adjusted for the other risk factors in the table except NNIS index
 Hemiarthroplasty
Register: NOIS  NHFR
Number infected / included:  103 / 1,416 (7.3%)  167 / 10,972 (1.5%)
Risk factor  A  B  C  D  E  F  G  H  I  J  K  L
Age group (years) 
  <60  22  1  0.8 0.1–5.8 0.8  4.0  145  7  3.6 1.6–7.8  0.001  5.1
  60–69  51  4  1.2 0.4–3.4 0.7  6.7  566  8  1.0 0.5–2.1  1.0  1.4
  70–79  318  19  1.0 0.6–1.6 0.9  6.0  2,634  41  1.1 0.8–1.7  0.5  1.6
  80–89  796  54  1        6.2  5,946  80  1        1.4
  ≥90  229  25  1.6 1.0–2.6 0.06  8.7  1,681  31  1.4 1.0–2.2  0.08  2.1
Sex 
  Female  1,053  82  1        7.0  8,085  115  1        1.5
  Male  363  21  0.8 0.5–1.3 0.3  4.8  2,887  52  1.3 1.0–1.9  0.08  2.0
ASA score 
  1  25  0              523  7  1        1.3
  2  592  43  1        7.3  3,854  58  1.2  0.5–2.6  0.6  1.5
  ≥3  799  60  1.1 0.7–1.6 0.8  8.2  6,595  102  1.3 0.6–2.8  0.5  1.6
Duration of surgery (min) 
  <60  271  26  1.9 1.0–3.9 0.06  7.8  2,371  47  1.4 0.9–2.0  0.1  2.2
  60–89  709  53  1.7  0.9–3.2  0.08  7.2  5,152  77  1        1.6
  90–119  317  13  1        3.7  2,598  30  0.8  0.5–1.2  0.2  1.2
  ≥120  119  11  2.2 1.0–4.9 0.06  8.0  851  13  0.9 0.5–1.7  0.7  1.4
Type of surgery 
  Emergency  1,041  81  1.3 0.8–2.0 0.8  6.9  9,459  137  0.8 0.5–1.1  0.2  1.5
  Planned  375  22  1        5.4  1,513  30  1        2.0
Method of fixation 
  Cemented  1,141  74  1        6.0  8,849  127  1        1.5
  Unemented  275  29  1.4 0.9–2.3 0.1  8.5  2,123  40  1.2 0.8–1.7  0.4  1.8
NNIS index a 
  0  452  32  1        7.2  3,436  54  1        1.6
  1  759  56  1.1 0.7–1.7 0.7  8.2  6.113  92  1.0 0.7–1.4  1.0  1.6
  ≥2  190  15  1.2 0.6–2.2 0.6  7.9  1.423  21  0.9 0.6–1.6  0.8  1.5
A–L: See table 3. 
a Adjusted for sex, age, type of surgery and method of fixation652  Acta Orthopaedica 2011; 82 (6): 646–654
a revision operation on hip arthroplasty is extensive surgery, 
and surgeons may sometimes choose a nonoperative approach 
in old and frail patients—an option that is not reported to the 
NAR and NHFR.
ASA class is a crude approximation of physical status, and 
works poorly at the individual level where there will be large 
inter–observer variability. In addition, different co–morbidi-
ties may have different effects on infection rates. However, 
ASA class has predictive value for complications in epidemio-
logical studies like the present one, where the number of cases 
is large (Ridgeway et al. 2005, Bjørgul et al. 2010). Thus, all 3 
registries have chosen the ASA classification as their measure 
of physical state. An ASA score higher than 1 had an increased 
risk of revision due to infection after THAs. This indicates 
that even minor co–morbidities may increase the risk of post-
operative infection. For patients with an infected prosthesis, 
the treatment strategy may be nonoperative for higher ASA 
classes. In the latter case, some surgeons may choose lifelong 
antibiotic suppression rather than reoperation for a low–grade 
implant infection. This may be one explanation for why higher 
ASA scores had no increased risk of revision due to infection 
after HA in our study. It may also be that ASA class does not 
capture frailty in the elderly in a sufficient way in our study 
population (Makary et al. 2010).
We could not confirm findings from previous studies that 
longer duration of surgery is associated with higher risk of SSI 
and higher risk of revision due to infection after THA (Små-
brekke et al. 2004, Ridgeway et al. 2005, Dale et al. 2009, 
Ong et al. 2009, Pedersen et al. 2010). However, duration of 
surgery less than 60 min was associated with higher risk of 
SSI after arthroplasty and risk of revision due to infection 
after HA. Similar findings were reported for SSI after revi-
sion arthroplasties, but not primary HA or THA, by Ridge-
way (2005). Rapid surgery may result in inferior soft tissue 
treatment and hemostasis, thereby leading to increased risk of 
infection.
Primary arthroplasty performed as an emergency procedure 
after a femoral neck fracture increased the risk of both SSI 
and revision due to infection after THA. Ridgeway (2005) also 
found trauma to be a risk factor for SSI after THA. This may 
be due to local or systemic reactions to the trauma itself, to 
frailty of the patients, or to other confounders not reported to 
the registers. For HAs, there was no difference in the risk of 
revision due to infection between arthroplasty performed in the 
acute phase and planned surgery. A primary arthroplasty per-
formed as planned surgery caused by a failed osteosynthesis 
is a reoperation, and may therefore resemble a revision 
arthroplasty more than a genuine primary arthroplasty. Revi-
sion arthroplasty and arthroplasty secondary to fractures are 
found to have higher susceptibility to infection (Berbari et al. 
1998, Ridgeway et al. 2005, Jämsen et al. 2009a).
Cementless fixation had a higher risk of revision due to 
deep infection after THA, but not a higher risk of SSI. In 
Norway, nearly all cemented THAs are inserted with cement 
containing antibiotics (The Norwegian Arthroplasty Register 
2010). Uncemented THAs can only be protected by antibi-
otic prophylaxis given systemically, and this was adminis-
tered in nearly all hip arthroplasties in Norway over the study 
period (The Norwegian Arthroplasty Register 2010). Anti-
biotic eluted from cement is delivered locally, and protects 
the implant and periprosthetic tissue (Espehaug et al. 1997, 
Engesæter et al. 2003, Hendriks et al. 2005, Dale et al. 2009). 
This local antibiotic treatment appears to be less effective for 
protection against SSI.
The NNIS risk index is a combined surgery–related assess-
ment tool developed to identify high–risk patients, and to eval-
uate the risk of SSI (Mangram et al. 1999). The NNIS index 
combines ASA class of greater than 2, duration of surgery 
longer than the 75th percentile for the procedure, and contami-
nation of the wound. Considering our findings on ASA class 
and duration of surgery, and that arthroplasty is a clean proce-
dure, the NNIS does not appear to be optimal for identification 
of patients who are at risk of infection after arthroplasty.
All data on completeness of case reporting to the NAR, 
the NHFR, and the NOIS, indicate that there would be minor 
selection bias in our study. The arthroplasties reported to the 
NOIS were similar, regarding the characteristics of patients 
and procedures, to the all–year–round registrations in the 
NAR and the NHFR. SSIs may have been underreported to 
the NOIS, just as revision due to infection has been to the 
NAR and other registers (Arthursson et al. 2005, Espehaug et 
al. 2006, Huotari et al. 2007, Jämsen et al. 2009b, Jämsen et al. 
2010b). There is also a possibility of overestimation of SSI in 
surveillance systems, as superficial infections may be difficult 
to distinguish from aseptic wound complications (Walenkamp 
2009). The lack of validation of endpoints is therefore a weak-
ness in our study, even though we performed separate analyses 
on overall and deep infections without any major changes in 
risk assessment. This should be addressed in future studies. 
Surgical policy was also a possible confounder in the present 
study on the NHFR and the NAR, since different subgroups—
such as patients with higher ASA classes and advanced age—
may have been subject to different treatment strategies. For 
the NOIS and the NHFR, the number of cases included makes 
statistical power an issue when differences between subgroups 
are small or the numbers are low.
The 2 endpoints of infection in our study may reflect differ-
ent types of infections, or at least different stages of infection. 
The NOIS is more likely to capture the acute virulent post-
operative infections whereas the NAR/NHFR is more likely 
to capture either a more advanced stage of infection or more 
low–grade, late infections. This fact will affect the findings 
of incidence and risk patterns of infection, and it is important 
for the interpretation of results of studies with different defini-
tions of infection and different follow–up.
The majority of SSIs were identified after discharge, which 
confirms earlier findings that post–discharge surveillance 
is important to capture the true incidence of SSI after hip Acta Orthopaedica 2011; 82 (6): 646–654  653
replacement (Huenger et al. 2005, Huotari and Lyytikainen 
2006, Mannien et al. 2008). Infection surveillance appears 
to reduce the incidence of SSI (Brandt et al. 2006), which is 
also the aim for the NOIS. The NAR has improved THA sur-
gery in Norway over the last 25 years (Fevang et al. 2010). 
In 2005, the NHFR was established on the same basis with 
the same methodology. This has led to changes in the treat-
ment of femoral neck fractures towards more use of HA (The 
Norwegian Hip Fracture Register 2010, Gjertsen et al. 2010). 
Adverse effects of such changes, such as infection, should be 
evaluated, which requires good–quality surveillance through 
registers like the NOIS, the NAR, and the NHFR.
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